NetworkNewsBreaks – Earth Science Tech Inc. (ETS
Post# of 333
(Total Views: 290)
Posted On: 04/18/2019 4:38:34 PM
NetworkNewsBreaks – Earth Science Tech Inc. (ETST) Expands Distribution of Full-spectrum CBD to Include Pharmacies
Earth Science Tech (OTCQB: ETST), an innovative biotechnology company, is increasing the distribution of its full-spectrum CBD product to wider markets, including pharmacies. Cowen & Co. research recently found that independent pharmacies appreciate the high margins and variation from larger chains offered by CBD oils (http://nnw.fm/fD89D). An article discussing the company reads, “‘CBD products appear to be gaining traction with independent pharmacies, many of whom are already selling or planning to sell CBD oils,’ analyst Charles Rhyee wrote in the Cowen report titled ‘Cowen’s Collective View of CBD’. ‘Independent pharmacies likely find the high-margin profile of CBD oils attractive, which we suspect is similar to those of more traditional over-the-counter drugs, as well as the differentiation it affords independents relative to larger chain pharmacies.’ . . . The Cowen analysis projects that CBD products in the United States will hit $16 billion by 2025 and reach 10 percent of U.S. adults. Cowen found in a survey of 2,500 adults that 6.9 percent of Americans already use CBD as a supplement (http://nnw.fm/p4E8k). Rhyee added that independent pharmacies like the exclusivity that CBD oils offer them in their competition with larger chains.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Earth Science Tech (OTCQB: ETST), an innovative biotechnology company, is increasing the distribution of its full-spectrum CBD product to wider markets, including pharmacies. Cowen & Co. research recently found that independent pharmacies appreciate the high margins and variation from larger chains offered by CBD oils (http://nnw.fm/fD89D). An article discussing the company reads, “‘CBD products appear to be gaining traction with independent pharmacies, many of whom are already selling or planning to sell CBD oils,’ analyst Charles Rhyee wrote in the Cowen report titled ‘Cowen’s Collective View of CBD’. ‘Independent pharmacies likely find the high-margin profile of CBD oils attractive, which we suspect is similar to those of more traditional over-the-counter drugs, as well as the differentiation it affords independents relative to larger chain pharmacies.’ . . . The Cowen analysis projects that CBD products in the United States will hit $16 billion by 2025 and reach 10 percent of U.S. adults. Cowen found in a survey of 2,500 adults that 6.9 percent of Americans already use CBD as a supplement (http://nnw.fm/p4E8k). Rhyee added that independent pharmacies like the exclusivity that CBD oils offer them in their competition with larger chains.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)